Surrey Heartlands

Joint Formulary & PAD

Clopidogrel - Stroke/TIA

You are here : Home > Formulary Search > Clopidogrel - Stroke/TIA

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green
Formulations :
  • Tablets
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
BNF SPC
Restrictions / Comments :

Documentation

Guidelines (Local)
Anti-Platelet Post stroke/TIA - Prescribing Guidance - Jun 2011
Evidence Review
Clopidogrel (generic) discussion paper APC Dec 2009
Letter to GP
Clopidogrel (generic) GP Letter Feb 10

PAD Profile

ChemicalSubstance :
Clopidogrel
Indication :
Stroke/TIA
Group Name :
Keywords :
Ischaemic stroke, transient ischaemic attack
Brand Names Include :
Plavix
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
3

Other Indications

Below are listed other indications that Clopidogrel is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Stroke/TIA.

Committee Recommendations (4)

03 May 17 - Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
GENERIC clopidogrel has been considered by the PCN and has been assigned a GREEN traffic light status.

NOTE - the branded product, Plavix, was considered BLACK at the PCN in May 2017.
28 Nov 12 - Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
The network members were informed of recent advice from the Royal College of Physicians which recommends that the management of patients after stroke and a TIA should be the same, this is outside of license and national guidance from NICE. The Royal College of Physicians recommend Clopidogrel as a first line treatment option for patients following a stroke or TIA. NHS Surrey already have guidelines in place and are in line with these recommendations.
10 Jun 11 - Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
The committee discussed recommendations regarding the use of antiplatelets in stroke / TIA which were produced by SWL following NICE guidance issued in 2010. This had been conisdered and supported by the Surrey Stroke & Heart Network noting that the use of clopidogrel in TIAs is off license and outside of NICE recommendations.
04 Dec 09 - Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
Despite all of the generic clopidogrel preparations having a license for use in ACS, there are some restrictions applied to their Marketing Authorisations. However, the committee were satisfied that this restriction was merely a Patent protection issue and would support the prescribing and dispensing of generic clopidogrel for all of their licensed indications including in combination with aspirin for ACS